Rapid and Effective Elimination of Myoglobin with CytoSorb® Hemoadsorber in Patients with Severe Rhabdomyolysis

被引:8
|
作者
Albrecht, Frederic [1 ,2 ]
Schunk, Stefan [2 ,3 ]
Fuchs, Maren [1 ,2 ]
Volk, Thomas [1 ,2 ]
Geisel, Juergen [2 ,4 ]
Fliser, Danilo [2 ,3 ]
Meiser, Andreas [1 ,2 ]
机构
[1] Saarland Univ, Med Ctr, Dept Anesthesiol Intens Care & Pain Therapy, Homburg, Germany
[2] Saarland Univ, Fac Med, Homburg, Germany
[3] Saarland Univ, Med Ctr, Dept Internal Med Nephrol & Hypertens 4, Homburg, Germany
[4] Saarland Univ, Med Ctr, Dept Clin Chem & Lab Med, Homburg, Germany
关键词
Acute kidney injury; Continuous renal replacement therapy; Hemoadsorber; Myoglobin; Renal replacement therapy; Rhabdomyolysis; HEMODIAFILTRATION; REMOVAL;
D O I
10.1159/000534479
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Rhabdomyolysis is characterized by destruction of muscle fibers by various causes and is diagnosed by increased creatine kinase concentrations in the blood. Myoglobin released into the blood may cause acute kidney injury. In this randomized controlled study, we hypothesized that myoglobin elimination would be faster when a hemoadsorber was added to a continuous veno-venous hemodialysis (CVVHD). Methods: Four patients in the control group received CVVHD with a high cut-off hemofilter using high blood and dialysate flows for 48 h. Four patients in the CytoSorb group received the same treatment, but in addition, the hemoadsorber CytoSorb (R) was inserted in front of the hemofilter and replaced once after 24 h. Blood samples were drawn simultaneously before (pre) and after (post) the hemofilter or else the hemoadsorber, after 5 and 30 min, as well as after 2, 4, 8, and 24 h. All measurements were repeated the next day after the hemoadsorber had been renewed in the CytoSorb group. Primary outcome was the area under the curve (AUC) of the relative myoglobin concentrations as percent of baseline. To evaluate the efficacy of myoglobin removal, relative reductions in myoglobin concentrations during one passage through each device at each time point were calculated. Results: Patients in the CytoSorb group had a significantly lower AUC during the first 24 h (42 +/- 10% vs. 63 +/- 6%, p = 0.029) as well as during the observation period of 48 h (26 +/- 7% vs. 51 +/- 12%, p = 0.029). The relative reductions for myoglobin were considerably higher in the CytoSorb group compared to the control group during the first 8 h. Conclusion: Myoglobin concentrations declined considerably faster when CytoSorb was added to a CVVHD. When compared to a high-cut-off hemofilter, efficacy of CytoSorb in myoglobin elimination was much better. Because of saturation after 8-12 h an exchange may be necessary.(c) 2023 The Author(s).Published by S. Karger AG, Basel
引用
收藏
页码:88 / 95
页数:8
相关论文
共 45 条
  • [31] MYOGLOBIN ELIMINATION IN END-STAGE KIDNEY-DISEASE PATIENTS ON RENAL REPLACEMENT TREATMENT
    STEFANOVIC, V
    BOGICEVIC, M
    MITIC, M
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1993, 16 (09) : 659 - 661
  • [32] RENAL ELIMINATION OF BETA-2-MICROGLOBULIN AND MYOGLOBIN IN PATIENTS WITH NORMAL AND IMPAIRED RENAL-FUNCTION
    FLOEGE, J
    WILKS, MF
    SOOSE, M
    KOTZERKE, J
    SHALDON, S
    KOCH, KM
    NEPHRON, 1990, 55 (04): : 361 - 367
  • [33] Evaluation of severe rhabdomyolysis on day 30 mortality in trauma patients admitted to intensive care: a propensity score analysis of the Traumabase registry
    Martinez, Thibault
    Harrois, Anatole
    Codorniu, Anais
    Mongardon, Nicolas
    Pissot, Matthieu
    Popoff, Benjamin
    Leone, Marc
    Delhaye, Nathalie
    Vicaut, Eric
    Mathais, Quentin
    Legros, Vincent
    Hanouz, Jean-Luc
    Gatulle, Nicolas
    Ramonda, Veronique
    Cohen, Benjamin
    Boutonnet, Mathieu
    Pottecher, Julien
    Libert, Nicolas
    CRITICAL CARE, 2024, 28 (01)
  • [34] Serum myoglobin as predictor of acute kidney injury and 90-day mortality in patients with rhabdomyolysis after exertional heatstroke: an over 10-year intensive care survey
    Wu, Ming
    Wang, Conglin
    Zhong, Li
    Liu, Zhifeng
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2022, 39 (01) : 446 - 454
  • [35] Utility of Serum Creatinine, Creatine Kinase and Urinary Myoglobin in Detecting Acute Renal Failure due to Rhabdomyolysis in Trauma and Electrical Burns Patients
    Preetish Bhavsar
    Kirtikumar Jagdish Rathod
    Darshana Rathod
    C. S. Chamania
    Indian Journal of Surgery, 2013, 75 : 17 - 21
  • [36] Utility of Serum Creatinine, Creatine Kinase and Urinary Myoglobin in Detecting Acute Renal Failure due to Rhabdomyolysis in Trauma and Electrical Burns Patients
    Bhavsar, Preetish
    Rathod, Kirtikumar Jagdish
    Rathod, Darshana
    Chamania, C. S.
    INDIAN JOURNAL OF SURGERY, 2013, 75 (01) : 17 - 21
  • [37] Rapid and effective antibiotics elimination from water by Fe-BTB MOF: An insight into adsorption mechanism
    Viltres, Herlys
    Phung, Vivian
    Gupta, Nishesh
    Morera-Boado, C.
    Sheikhlar, Ahmad Mohammadi
    Rajabzadeh, Amin Reza
    Srinivasan, Seshasai
    JOURNAL OF MOLECULAR LIQUIDS, 2024, 397
  • [38] Effective elimination of high-dose methotrexate by repeated hemodiafiltration and high-flux hemodialysis in patients with acute kidney injury
    Sakran, Razan
    Milo, Gai
    Jabareen, Ali
    Artul, Tareq
    Haim, Nissim
    Litvak, Michael
    Ringelstein-Harlev, Shimrit
    Horowitz, Nethanel
    Efrati, Edna
    Assady, Suheir
    Kurnik, Daniel
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (02) : 508 - 515
  • [39] Rapid and Effective Lead Elimination Using Cow Manure Derived Biochar: Balance between Inherent Phosphorus Release and Pollutants Immobilization
    Wang, Huabin
    Wen, Yi
    Ding, Yu
    Yue, Zhiqiang
    Xu, Dan
    Liu, Ying
    Zhang, Yong
    Xu, Rui
    Zeng, Weiqing
    TOXICS, 2023, 11 (01)
  • [40] Severe statin-induced rhabdomyolysis mimicking Guillain-Barre syndrome in four patients with diabetes mellitus treated with fusidic acid
    Collidge, T. A.
    Razvi, S.
    Nolan, C.
    Whittle, M.
    Stirling, C.
    Russell, A. J. C.
    Mann, A. C.
    Deighan, C. J.
    DIABETIC MEDICINE, 2010, 27 (06) : 696 - 700